concept

PROTEIN AGGREGATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PROTEIN AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

657Connections

2Hypotheses

13Analyses

50Outgoing

50Incoming

0Experiments

16Debates

Summary

PROTEIN AGGREGATION is a concept in neurodegeneration research. Key relationships include: associated with, co discussed, regulates. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 49 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	PROTEIN AGGREGATION
Key Genes/Proteins	AKT, ALPHA-SYNUCLEIN, AMYLOID, APP, CGAS, CTSD
Related Diseases	AGING, ALS, ALZHEIMER, APOPTOSIS, CERAMIDE

Wiki Pages (1)

Knowledge base pages for this entity

Protein Aggregation in Neurodegeneration

mechanism · 2428 words

Pathway Diagram

graph TD
    PROTEIN_AGGREGATION["PROTEIN AGGREGATION"]
    PROTEIN_AGGREGATION -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    PROTEIN_AGGREGATION -->|"activates"| Neuroinflammation["Neuroinflammation"]
    Autophagy_lysosomal_pathway["Autophagy-lysosomal pathway"] -.protects against.-> PROTEIN_AGGREGATION
    autophagy_lysosomal_pathway["autophagy-lysosomal pathway"] -.protects against.-> PROTEIN_AGGREGATION
    autophagy["autophagy"] -.protects against.-> PROTEIN_AGGREGATION
    Neuroinflammation -->|"activates"| PROTEIN_AGGREGATION
    CERS2["CERS2"] -->|"inhibits"| PROTEIN_AGGREGATION
    CHMP2A["CHMP2A"] -->|"activates"| PROTEIN_AGGREGATION
    CHMP2B["CHMP2B"] -->|"activates"| PROTEIN_AGGREGATION
    CHMP6["CHMP6"] -->|"activates"| PROTEIN_AGGREGATION
    COMPLEMENT["COMPLEMENT"] -->|"expressed in"| PROTEIN_AGGREGATION
    PTN["PTN"] -->|"expressed in"| PROTEIN_AGGREGATION

Outgoing (92)

Target	Relation	Type	Str
alzheimer_disease	associated_with	disease	0.95
neurodegeneration	causes	process	0.95
neurodegenerative diseases	contributes_to	disease	0.95
Neurodegeneration	associated_with	disease	0.95
Amyloid	associated_with	protein	0.95
Neurodegenerative Diseases	causes	disease	0.95
Alzheimer's Disease	causes	disease	0.95
Neurodegenerative Diseases	associated_with	disease	0.92
Neuroinflammation	causes	process	0.90
Alzheimer's Disease	mediates	disease	0.90
neurodegeneration	mediates	phenotype	0.90
Huntington's Disease	causes	disease	0.90
Neuronal Degeneration	contributes_to	process	0.90
Parkinson's Disease	causes	disease	0.90
Alzheimer's Disease	causes	disease	0.90
Tau	involved_in	protein	0.90
Neuroplasticity	associated_with	process	0.90
alzheimer_disease	involved_in	disease	0.90
Amyloid-Beta	involved_in	protein	0.90
Alzheimer's Disease	contributes_to	disease	0.90
Neurodegenerative Disease	causes	disease	0.90
SOLUBLE OLIGOMERS	associated_with	protein	0.90
Neurodegeneration	causes	process	0.85
Amyotrophic Lateral Sclerosis	biomarker_for	disease	0.85
ALZHEIMER'S DISEASE	causes	disease	0.85
detergent-insoluble proteome	contributes_to	process	0.85
pathological spreading	causes (protein aggregation drives cell-to-cell spreading )	mechanism	0.85
Alzheimer's Disease	contributes_to	disease	0.85
geographic atrophy	promotes	phenotype	0.80
microglial_activation	associated_with	mechanism	0.80
glymphatic_clearance	correlates_with	mechanism	0.80
oxidative_stress	associated_with	phenotype	0.80
Amyotrophic Lateral Sclerosis	causes	disease	0.75
Alzheimer's disease	causes	disease	0.70
neuronal loss	promotes	process	0.70
Neuroinflammation	activates	process	0.70
inflammation	promotes	process	0.70
SIRT1 reduction	causes	process	0.70
SENESCENCE	interacts_with	phenotype	0.65
SNCA	activates	gene	0.60
PROTEOSTASIS	targets	phenotype	0.60
α-SYNUCLEIN	activates	concept	0.50
NUCLEUS	activates	concept	0.50
Proteins	interacts_with	protein	0.50
NUCLEUS	interacts_with	concept	0.50
NEURODEGENERATIVE DISEASE	associated_with	concept	0.50
ALZHEIMER'S	activates	concept	0.50
HUNTINGTON'S	activates	concept	0.50
FRONTOTEMPORAL	associated_with	concept	0.50
ALZHEIMER'S	associated_with	concept	0.50

Incoming (565)

Source	Relation	Type	Str
RNA G-quadruplexes	mediates	process	0.95
Tardbp	promotes	protein	0.92
HNRNPA2B1	contributes_to	protein	0.92
Parkin	regulates	protein	0.90
SNCA	involved_in	protein	0.90
Amyloid-Beta	involved_in	protein	0.90
TARDBP	associated_with	protein	0.90
PRKAA2	regulates	gene	0.90
mutant THAP11	causes	unknown	0.90
phase separation	drives	process	0.90
Autophagy	associated_with	process	0.90
SQSTM1	regulates	gene	0.90
GCase	associated_with	protein	0.90
Intrinsically Disordered Low-Complexity Domain	contributes_to	mechanism	0.90
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	gene	0.90
Neuroinflammation	upregulates	process	0.90
Molecular Chaperones	suppresses	protein	0.90
Intra-Condensate Demixing	mediates	process	0.90
Proteostasis Disruption	causes	process	0.90
DNAJB6	inhibits	protein	0.90
TAU	associated_with	protein	0.90
tau	promotes	protein	0.90
HSP90	suppresses	protein	0.90
oxidative_stress	causes	phenotype	0.90
40624017	induces	paper	0.90
HTT	promotes	gene	0.90
Tdp-43	drives	protein	0.90
amyloid-beta peptide	promotes	compound	0.90
Neurodegeneration-Associated Proteins Accumulation	promotes	phenotype	0.90
HSPB8	modulates	protein	0.88
Inflammasome	associated_with	pathway	0.88
SQSTM1	prevents	protein	0.87
chaperone-mediated autophagy	suppresses	process	0.85
Endoplasmic Reticulum Dysfunction	contributes_to	process	0.85
HSPB8 FRAMESHIFT MUTANT	contributes_to	protein	0.85
Autophagy	suppresses	process	0.85
Environmental Stress	promotes	process	0.85
oxidative_stress	contributes_to	phenotype	0.85
GCase	contributes_to	protein	0.85
intrinsically disordered domain	promotes	phenotype	0.85
glymphatic_clearance	inhibits	mechanism	0.85
protein over-synthesis	promotes	process	0.85
alzheimer_disease	associated_with	disease	0.85
GCase	involved_in	protein	0.85
Proteostasis Network	regulates	pathway	0.85
HSP27	suppresses	protein	0.85
Protein Clearance Enhancement	suppresses	pathway	0.85
Cytoskeletal Disruption	promotes	process	0.85
P62	biomarker_for	protein	0.85
protein oligomers	involved_in	protein	0.85

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-complement-amyloid axis as therapeutic target for prot	0.550	unknown	-
Protein Aggregation-Epigenetic Stress Response Modulation	0.000	-	Epigenetic clocks and biological aging i

Mentioning Analyses (13)

Scientific analyses that reference this entity

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

neurodegeneration | 2026-04-27 | 0 hypotheses

Microglial senescence in Alzheimer and Parkinson disease progression

neurodegeneration | 2026-04-26 | 0 hypotheses

Is ferroptosis the primary driver of motor neuron death in ALS or an epiphenomen

neurodegeneration | 2026-04-18 | 4 hypotheses Top: 0.538

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (16)

Multi-agent debates referencing this entity

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

closed · Rounds: 6 · Score: 0.89 · 2026-04-27

Debate: Chromatin Remodeling-Mediated Nutrient Sensing Restoration

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Hypothesis debate: Nutrient-Sensing Epigenetic Circuit Reactivation

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Microglial senescence in Alzheimer and Parkinson disease progression

closed · Rounds: 6 · Score: 0.50 · 2026-04-25

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

closed · Rounds: 4 · Score: 0.79 · 2026-04-21

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The core causation versus correlation debate remains unresolved despite being ce

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate highlighted compelling correlative evidence for ferroptosis markers i

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Can computationally designed binders against alpha-synuclein realistically trans

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

closed · Rounds: 4 · Score: 0.92 · 2026-04-16

Related Research

Hypotheses and analyses mentioning PROTEIN AGGREGATION in their description or question text

No additional research found